UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6 - K

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a - 16 or 15d -16

Under the Securities Exchange Act of 1934

 

For the Month of July, 2019

 

Commission file number 001-14184

 

B.O.S. Better Online Solutions Ltd.

(Translation of Registrant’s Name into English)

 

20 Freiman Street, Rishon LeZion, 7535825, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___________

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___________

 

 

 

 

 

  

B.O.S. Better Online Solutions Ltd.

 

This Form 6-K, including the exhibit, is hereby incorporated by reference into all effective registration statements, filed by us under the Securities Act of 1933, as amended, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Attached hereto is the following exhibit:

 

99.1 Imdecol Ltd. Audited Consolidated Financial Statements for the year ended December 31, 2018.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  B.O.S. Better Online Solutions Ltd.
  (Registrant)
     
  By: /s/ Eyal Cohen
    Eyal Cohen
    Co-Chief Executive Officer and
Chief Financial Officer

 

Dated: July 29, 2019

 

2

 

 

EXHIBIT INDEX

 

EXHIBIT NO.   DESCRIPTION
     
99.1   Imdecol Ltd. Audited Consolidated Financial Statements for the year ended December 31, 2018.

 

 

3

 

 

Exhibit 99.1

 

 

 

 

 

 

 

 

 

 

The Consolidated
Financial Statements of
Imdecol Ltd.
As of December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Imdecol Ltd.

 

Financial Statements as of December 31, 2018

 

Table of Contents

 

  Page
   
Independent Auditor’s Report 1
   
Balance Sheets 2 -3
   
Statement of Operations 4
   
Statements of Stockholders’ Deficit 5
   
Statement of Cash Flows 6
   
Notes to the Financial Statements 7-15

 

i

 

Independent Auditor’s Report

 

To the Board of Directors and/or Shareholders

 

We have audited the accompanying financial statements of Imdecol Ltd., which comprise the balance sheet as of December 31, 2018, and the related statements of operation, stockholders’ deficit, and cash flows for the year then ended, and the related notes to the financial statements.

 

Management’s Responsibility for the Financial Statements

 

Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

Auditor’s Responsibility

 

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

 

Opinion

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Imdecol Ltd. as of December 31, 2018, and the results of their operations and their cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.

 

/s/ Alan Moldof

 

Jerusalem, Israel

24/07/19

 

1

 

Imdecol Ltd.
Balance Sheets

 

        As of
December 31
2018
 
    Notes   $  
ASSETS          
Curret Assets          
Cash and cash equivalents         77,666  
Accounts receivable         358,503  
Other receivables   4     173,952  
Inventories   3     550,802  
Total Curret Assets         1,160,923  
             
Deferred tax assets         130,398  
             
Fixed Assets, Net   5     100,482  
             
TOTAL ASSETS         1,391,803  

 

2

 

  Imdecol Ltd.
Balance Sheets

 

        As of  
        December 31  
        2018  
    Notes   $  
LIABILITY AND STOCKHOLDERS’ DEFICIT          
Current Liabilities          
Short-term credit   6     332,708  
Accounts payable   7     941,339  
Other payables   8     440,337  
             
Total Current Liabilities         1,714,384  
             
Non Current Liabilities            
Bank loans   9     169,979  
Loan from related party         33,351  
          203,330  
             
Employee benefit obligations   10     151,011  
             
Total Liabilities         2,068,725  
             
Stockholders’ deficit            
Common stock, 1 NIS par value; 36,600 share authorized; 130 shares issued and outstanding at December 31, 2018 and 2017.   11     27  
Other comprehensive income         (54,384 )
Accumulated deficit         (622,565 )
             
Total stockholders’ deficit         (676,922 )
             
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT         1,391,803  

 

 

Director

May 20, 2019

The accompanying notes are an integral part of that financial statements.

 

3

 

  Imdecol Ltd.

Statement of Operations

 

        Year ended
December 31
2018
 
        $  
Revenues         5,379,440  
Cost of sales         (3,724,671 )
Gross profit         1,654,769  
General and administrative costs         (1,296,885 )
Profit before finance costs         357,884  
Finance costs, net   13     (94,602 )
Profit before taxation         263,282  
Income tax expense         (73,971 )
Net profit         189,311  
             
Net Profit per common share - basic and diluted            
Net Profit per share attributable to common stockholders         1,456.24  
Weighted-average number of common shares outstanding         130  

 

The accompanying notes are an integral part of that financial statements.

 

4

 

  Imdecol Ltd.

Statements of Stockholders’ Deficit

 

                Other     Accumulated     Total  
                comprehensive     eqity     shareholders’  
          Amount     income     (deficit)     deficit  
    Shares     $  
December 31, 2017     13,517,625,000       27       (120,681 )     (811,876 )     (932,530 )
Profit for the year     -       -       66,297       189,311       255,608  
Balance of December 31, 2018     130       27       (54,384 )     (622,565 )     (676,922 )

 

The accompanying notes are an integral part of that financial statements.

 

5

 

  Imdecol Ltd.

Statement of Cash Flows

 

    Year ended
December 31
2018
 
    $  
Cash flows from operating activities      
Net profit     189,311  
         
Adjustments for non-cash income and expenses        
Provision for severance pay     30,668  
Depreciation     24,023  
Changes in other comprehensive income     66,297  
Decrease in deferred tax assets     87,269  
      208,257  
Changes in operating assets and liabilities        
Decrease in accounts receivable     196,885  
Decrease in other receivables     111,912  
Decrease in inventory     253,846  
Decrease in accounts payable     (772,198 )
Decrease in other payables     (390,897 )
      (600,452 )
Net cash used in operating activities     (202,884 )
         
Cash flows from investing activities        
Acquisition of fixed assets     (2,444 )
Net cash used in investing activities     (2,444 )
         
Cash flows from financing activities        
Proceeds from short term loan from banks     53,557  
Repayment of long terms loans     (17,298 )
Proceeds from loan with related parties     133,405  
Net cash earned in financing activities     169,664  
         
Decrease in cash and cash equivalents     (35,664 )
Cash and cash equivalents at the beginning of the year     113,330  
Cash and cash equivalents at the end of the year     77,666  

 

The accompanying notes are an integral part of that financial statements.

 

6

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 1 - Nature of business of presentation

 

Imdecol Ltd. (the “Company”) is an Israeli privately owned company, Established in 1998.

Imdecol is a leading supplier of high-performance Tailor made robotic systems for the Industrial market.

Specializing in IML solutions for the plastic industry and automation systems for vast range of industries

 

Basis of Presentation

 

The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).

 

These financial statements are presented in US dollars.

 

Fiscal Year End

 

The Corporation has adopted a fiscal year end of December 31.

 

Note 2 - Summary of significant accounting policies

 

The principal accounting policies are set out below, these policies have been consistently applied to the period presented, unless otherwise stated:

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts or revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Foreign Currencies

 

Assets and liabilities recorded in foreign currencies are translated at the exchange rate on the balance sheet date. Revenue and expenses are translated at average rates of exchange prevailing during the year. Translation adjustments resulting from this process are recorded to other comprehensive income (“OCI”).

 

Cash and cash equivalents

 

Cash and equivalents include investments with initial maturities of three months or less. The Company maintains its cash balances at credit-worthy financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000.

 

Accounts Receivable

 

The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Based on historical collection activity, the Company had no allowances for bad debts at December 31, 2018 and 2017.

 

Inventories

 

Inventories are stated at average cost, subject to the lower of cost or market. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our suppliers, and the estimated utility of our inventory. If our review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of revenue. The determination of market value and the estimated volume of demand used in the lower of cost or market analysis require significant judgment.

 

7

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 2 - Summary of significant accounting policies (Cont.)

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using shorter of useful live of the property or the unit of depletion method. For shorter-lived assets the straight-line method over estimated lives ranging from 3 to 10 years is used as follows:

 

Furniture 6-7 years
   
Capital Improvements 10 years
   
Computers and Electronic Equipments 3-10 years

 

Impairment Long-Lived Assets

 

For purposes of recognition and measurement of an impairment loss, a long-lived asset or assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses the impairment of long-lived assets (including identifiable intangible assets) annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

 

When management determines that the carrying value of long-lived assets may not be recoverable based upon the existence of one or more of the above indicators of impairment, we test for any impairment based on a projected undiscounted cash flow method. Projected future operating results and cash flows of the asset or asset group are used to establish the fair value used in evaluating the carrying value of long-lived and intangible assets. The Company estimates the future cash flows of the long-lived assets using current and long-term financial forecasts. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If this were the case, an impairment loss would be recognized. The impairment loss recognized is the amount by which the carrying amount exceeds the fair value.

 

Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses are carried at amortized cost and represent liabilities for goods and services provided to the Company prior to the end of the financial year that are unpaid and arise when the Company becomes obliged to make future payments in respect of the purchase of these goods and services.

 

Earnings per Share

 

The Company computes net loss per share in accordance with ASC 260, “Earnings Per Share” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potential dilutive common shares, which comprise options granted to employees. As December 31, 2018, the Company had no potentially dilutive shares.

 

Income Taxes

 

Income taxes are accounted for in accordance with ASC Topic 740, “Income Taxes.” Under the asset and liability method, deferred tax assets and liabilities are recognized for the future consequences of differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases (temporary differences). Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are recovered or settled. Valuation allowances for deferred tax assets are established when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Revenue Recognition

 

The Company recognizes revenue when all of the following have occurred: persuasive evidence of an agreement with the customer exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectability of the selling price is reasonably assured.

 

8

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 2 - Summary of significant accounting policies (Cont.)

 

Cost of Sales

 

Cost of sales includes all of the costs to manufacture the Company’s products. For products manufactured in the Company’s own facilities, such costs include raw materials and supplies, direct labour and factory overhead. For products manufactured for the Company by third-party contractors, such cost represents the amounts invoiced by the contractors.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

-       Level 1: Quoted prices in active markets for identical instruments;

 

-       Level 2: Other significant observable inputs (including quoted prices in active markets for similar instruments);

 

-       Level 3: Significant unobservable inputs (including assumptions in determining the fair value of certain investments).

 

Recently Issued Accounting Pronouncements

 

In July 2015, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2015-11 “Simplifying the Measurement of Inventory”; guidance which requires inventory within the scope of the standard to be measured at the lower of cost and net realizable value. Previous guidance required inventory to be measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin). The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2016, with early adoption permitted. There were various other updates recently issued, none of which are expected to a have a material impact on the Company’s financial position, results of operations or cash flows.

 

Note 3 - Inventories

 

   

As of

December 31 2018

 
    $  
Raw material     178,312  
Work in process     372,490  
Total inventory     550,802  

 

9

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 4 - Other receivables

 

    As of
December 31
2018
 
  $  
Advance payments to suppliers     29,103  
Prepaid expenses     20,148  
Institutions     11,335  
Related parties     113,366  
      173,952  

 

Note 5 - Fixed Assets, Net

 

                Capital        
    Vehicles     Furniture     Improvments     Total  
    $  
Cost                        
Balance as at January 1, 2018     -       149,344       139,150       288,494  
Current year     -       2,444       -       2,444  
Balance as at December 31, 2018     -       151,788       139,150       290,938  
                                 
Accumulated Depreciation                                
Balance as at January 1, 2018     -       117,323       49,110       166,433  
Disposals     -       11,158       12,865       24,023  
Balance as at December 31, 2018     -       128,481       61,975       190,456  
                                 
Fixed Assets, Net as at December 31, 2018     -       23,307       77,175       100,482  

 

Note 6 - Short-term credit

 

   

As of

December 31 2018

 
      $  
Short term loan     53,557  
Current maturities     279,151  
      332,708  

 

10

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 7 - Accounts payable

 

   

As of

December  31

2018

 
      $  
Trade creditors     636,252  
Outstanding checks     305,087  
      941,339  

 

Note 8 - Other payables

 

   

As of

December 31

2018

 
      $  
Institutions     31,175  
Accrued expenses     141,131  
Advance from customers     116,851  
Employees     151,180  
      440,337  

 

Note 9 - Bank loans

 

The loans are:

 

         

As of

December 31 2018

 
    interest rates     $  
Linked to the prime interest rate     3.5-4.5%       77,097  
Linked to the prime interest rate     5.1-6.3%       271,979  
              349,076  

 

11

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 10 - Employee benefit obligations

 

Israeli law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances.

 

The following principal plans relate to the employees in Israel:

 

Most of the company’s employees are subject to higher deposit fund which eliminate the company from any obligation (according to paragraph 14 of the Severance Pay Law (1963)).

 

For the employees whom are not subject paragraph 14, the Company’s liability for severance pay for its employees is calculated pursuant to Israeli severance pay law based on the most recent salary of the employee multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month’s salary for each year of employment, or a portion thereof. The Company’s liability for all of its Israeli employees is partially provided for by monthly deposits in insurance policies and the remainder by an accrual in the financial statements. The value of these policies is recorded as an asset in the Company’s balance sheet.

 

The deposited funds include profits/loss accumulated up to the balance sheet date. The value of the deposited funds is based on current redemption value of these policies. Withdrawals from the funds may be made only upon termination of employment.

 

Note 11 - Capital Stock

 

Common stock

 

Common stock, 1 NIS par value; 36,600 share authorized; 130 shares issued and outstanding at December 31, 2018 and 2017.

 

12

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 12 - Income taxes

 

The provision (benefit) for income taxes for the years ended December 31, 2018 and December 31, 2017 was follows (assuming a 23% effective tax rate):

 

    December 31,  
    2018  
    $  
Current tax provision:        
Federal-     -  
Taxable income     -  
Total current tax provision     -  
       
    December 31,  
    2018  
    $  
Deferred Tax Provision:        
Federal-        
Loss carry forwards     (73,971 )
Change in valuation allowance     73,971  
Total deferred tax provision     -  

 

The Company had deferred income tax assets as of December 31, 2018 and December 31, 2017 as follows:

 

    December 31  
    2018  
    $  
Loss carryforwards     130,398  
Less - Valuation allowance     (130,398 )
Total net deferred tax assets     -  

 

The Company provided a valuation allowance equal to the deferred income tax assets for year ended December 31, 2018 because it is not presently known whether future taxable income will be sufficient to utilize the loss carryforwards.

 

As of December 31, 2018, the Company had approximately $676,922 in tax loss carryforwards that can be utilized future periods to reduce taxable income.

 

The Company did not identify any material uncertain tax positions. The Company did not recognize any interest or penalties for unrecognized tax benefits.

 

13

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 13 - Finance costs,/income, net

 

    Year ended December 31 2018  
    $  
Finance costs        
Bank institutions     47,914  
Others     3,354  
Institutions     1,470  
Exchange rate differences     41,864  
      94,602  

 

Note 14 - Related party transactions

 

Details of transaction between the Company and related parties are disclosed below:

 

The following entities have been identified as related parties:

 

Ben Zion Katz -Director and greater than 10% stockholder
Ayelet Hayak -CEO and Greater than 10% stockholder

 

The following balances exist with related parties:

 

    Year ended December 31 2018  
    $  
Short term loan to Related Parties     (113,366 )
Current mturiality of long term loans     100,053  
Long term loan from Related Parties     33,351  
Payables - Related parties     4,279  
    24,317  

 

INCOME STATEMENT

 

The following transactions were carried out with related parties:

 

    Year ended December 31 2018  
    $  
Directors and CEO compensation     291,110  

 

14

 

Imdecol Ltd.

Notes to the Financial Statements

 

Note 15 - Subsequent events

 

On March 19, 2019 B.O.S. Better Online Solutions Ltd. (“BOS”), signed a definitive agreement to purchase the assets of Imdecol Ltd., a global integrator and manufacturer of automatic and robotic systems that enhance the productivity of production lines. The transaction is expected to close by June 1, 2019.

 

The purchase price of Imdecol’s business is based on a multiple of four times the average annual operating profit of Imdecol’s business for the years 2017, 2018, 2019 and for the 12 months ended June 30, 2020.

 

The purchase price consists of a combination of cash and ordinary shares of BOS, payable as follows:

 

  NIS 1 million (approximately $280,000) was paid to Imdecol upon signing the definitive agreement. This amount was extended initially as a bridge loan, which bears interest at 10% per annum and is secured by a first degree fixed pledge and charge on the shares of the shareholders of Imdecol. At closing, the loan shall be applied towards the purchase price. The loan shall become due and payable if closing is not effected by August 31, 2019.
     
  An additional NIS 4.5 million (approximately $1.25 million) shall be paid to Imdecol at closing.
     
  NIS 1.5 million (approximately $417,000) shall be paid to Imdecol no later than August 2020, by way of issuance of BOS’s ordinary shares. The value of the ordinary shares will be determined according to their market price prior to issuance and the shares will be subject to a lock-up period until June 2022.
     
  An additional amount in cash may be paid by August 2020, based on the performance of the Imdecol business through June 2020.
     
  In addition, BOS will acquire Imdecol’s inventory at its book value on the closing date, which is estimated at NIS 2.6 million (approximately $720,000). BOS will pay an advance of NIS 1.5 million (approximately $417,000) upon closing and the balance will be paid on an ongoing basis as the inventory is consumed. The cash portion of the acquisition price will be financed mainly through a combination of commercial bank loans and internal cash resources.

 

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

 

 

15